Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 177,866,592
  • Shares Outstanding, K 403,646
  • Annual Sales, $ 803,400 K
  • Annual Income, $ -747,060 K
  • 60-Month Beta 1.48
  • Price/Sales 218.28
  • Price/Cash Flow N/A
  • Price/Book 25.09
Trade MRNA with:

Options Overview

Details
  • Implied Volatility 61.14%
  • Historical Volatility 60.09%
  • IV Percentile 18%
  • IV Rank 11.56%
  • IV High 131.61% on 12/01/20
  • IV Low 51.93% on 06/08/21
  • Put/Call Vol Ratio 0.73
  • Today's Volume 244,359
  • Volume Avg (30-Day) 151,783
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 584,779
  • Open Int (30-Day) 532,728

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 9.45
  • Number of Estimates 8
  • High Estimate 11.47
  • Low Estimate 8.28
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +1,701.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
362.80 +18.54%
on 08/30/21
464.85 -7.49%
on 09/10/21
+28.19 (+7.01%)
since 08/17/21
3-Month
194.51 +121.09%
on 06/18/21
497.49 -13.56%
on 08/10/21
+227.58 (+112.40%)
since 06/17/21
52-Week
63.64 +575.75%
on 09/24/20
497.49 -13.56%
on 08/10/21
+362.16 (+533.45%)
since 09/17/20

Most Recent Stories

More News
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots

/PRNewswire/ --   -  Using the same technology as their Covid-19 shot, scientists behind the and (NASDAQ:AZN) are getting closer to developing a , based on promising animal studies results. Based...

AZN : 55.56 (-1.84%)
BIOV.CN : 0.540 (+24.14%)
BVAXF : 0.4236 (+26.07%)
BNTX : 359.18 (-3.61%)
MRNA : 430.05 (-2.41%)
CVAC : 55.11 (unch)
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots

VANCOUVER – USA News Group – Using the same technology as their Covid-19 shot, scientists ...

BVAXF : 0.4236 (+26.07%)
AZN : 55.56 (-1.84%)
BNTX : 359.18 (-3.61%)
MRNA : 430.05 (-2.41%)
CVAC : 55.11 (unch)
BIOV.CN : 0.540 (+24.14%)
Moderna (MRNA) Gains As Market Dips: What You Should Know

Moderna (MRNA) closed the most recent trading day at $440.65, moving +1.42% from the previous trading session.

MRNA : 430.05 (-2.41%)
NetworkNewsAudio Lexaria Bioscience Corp. (NASDAQ: LEXX) Leading Out in Innovation of Hypertension Treatment

(MENAFN - Investor Brand Network) Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States, or 108 million people, have hypertension, yet only about...

LEXX : 6.32 (+2.93%)
PFE : 43.89 (-1.30%)
MRK : 71.68 (-0.40%)
AZN : 55.56 (-1.84%)
MRNA : 430.05 (-2.41%)
Moderna Announces Health Canada Approves its COVID-19 Vaccine

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced Health Canada has approved the New Drug Submission (NDS-CV) for SPIKEVAX(TM)...

MRNA : 430.05 (-2.41%)
Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet

Amid rising coronavirus cases, PFE and MRNA are trying to make booster doses of their COVID-19 vaccine available for US citizens. An FDA meeting is scheduled tomorrow to discuss Comirnaty's booster dose....

AZN : 55.56 (-1.84%)
JNJ : 164.75 (-0.28%)
PFE : 43.89 (-1.30%)
MRNA : 430.05 (-2.41%)
NVAX : 237.54 (+0.11%)
BNTX : 359.18 (-3.61%)
Here's Why You Should Retain QIAGEN (QGEN) Stock For Now

Investors are optimistic about QIAGEN (QGEN) owing to impressive sales of diagnostic solutions and strong international growth.

VRTX : 188.30 (+0.64%)
QGEN : 54.34 (+0.35%)
MRNA : 430.05 (-2.41%)
HZNP : 109.71 (+1.63%)
Gold Weakness Weighs on Futures

Canada's main stock index futures fell to a three-week low on Thursday, weighed by weakness in gold ...

MRNA : 430.05 (-2.41%)
Stock Market News For Today September 16, 2021

SPY : 441.40 (-1.29%)
PEP : 154.13 (-0.92%)
CVX : 96.76 (-0.58%)
MRNA : 430.05 (-2.41%)
ADBE : 654.48 (-1.60%)
Green Across the Board at Closing Bell

All four market indexes are off the recent highs we saw last Thursday, so even today's healthy trading environment wasn't enough.

MSFT : 299.87 (-1.75%)
MRNA : 430.05 (-2.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

3rd Resistance Point 480.87
2nd Resistance Point 461.44
1st Resistance Point 445.74
Last Price 430.05
1st Support Level 410.61
2nd Support Level 391.18
3rd Support Level 375.48

See More

52-Week High 497.49
Last Price 430.05
Fibonacci 61.8% 331.76
Fibonacci 50% 280.57
Fibonacci 38.2% 229.37
52-Week Low 63.64

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar